Serena Williams is getting real about her weight-loss journey. Since April, the retired tennis legend has been on a GLP-1 ...

Serena Williams has been taking a GLP-1 medication to help with her recent weight loss, she revealed for the first time in an ...

Serena Williams reveals her use of GLP-1, Zepbound and calls out the stigma surrounding the use of the popular weight loss drug.

Serena Williams wants to be transparent and is opening up about her fitness journey, revealing she's taking a GLP-1 ...

For reasons that remain unclear, kidney cancer risk was higher in users of GLP-1 agonists, particularly those under 65 and those who were overweight versus obese.< Patients taking GLP-1 agonists for ...

Serena Williams is showing off her 31-pound weight loss after going on the GLP-1 medication Ro. “I feel great,” Williams, 43, ...

The 23-time Grand Slam champion recently opened up to PEOPLE exclusively about using a GLP-1 medication to help with weight ...

Williams, 43, in a new series of interviews, is revealing that GLP-1s are responsible for a recent 31-pound slim down. "I was on and off (the medication) and now completely on," she told ...

But what is important to me is transparency.” That calling has led her to this very moment: Williams is ready to share that ...

Serena Williams shares she is now using a GLP-1 in partnership with Ro, a digital health care company. Find out why she’s not ...

As someone who had built her career on grit and hard work, Williams hesitated before exploring weight-loss medications ...

GLP-1 receptor agonists may outperform metformin in lowering the risk for dementia, particularly Alzheimer’s disease and other nonvascular types, in patients with type 2 diabetes.